Your browser doesn't support javascript.
loading
Medication therapy of high-dose methotrexate: An evidence-based practice guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society.
Song, Zaiwei; Hu, Yang; Liu, Shuang; Wang, Guanru; Zhai, Suodi; Zhang, Xianglin; Li, Youping; Du, Guanhua; Shi, Yuankai; Chen, Yaolong; Dong, Mei; Guo, Ruichen; Guo, Wei; Huang, Hongbing; Huang, Xiaojun; Jing, Hongmei; Ke, Xiaoyan; Li, Guohui; Miao, Liyan; Niu, Xiaohui; Qiu, Feng; Shen, Jingnan; Tang, Jingyan; Wang, Tianyou; Wang, Xiaoling; Wang, Zhuo; Wu, Jiuhong; Zhan, Siyan; Zhang, Bikui; Zhang, Lingli; Zhang, Yanhua; Zhang, Wei; Zhao, Limei; Zhao, Libo; Zhen, Jiancun; Zheng, Huyong; Zhu, Zhu; Jiang, Dan; Huang, Zhencheng; Tan, Zhiyuan; Lin, Qiaonan; Zhao, Rongsheng.
Afiliação
  • Song Z; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Hu Y; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
  • Liu S; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Wang G; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Zhai S; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
  • Zhang X; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Li Y; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Du G; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
  • Shi Y; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Chen Y; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Dong M; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
  • Guo R; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Guo W; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Huang H; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
  • Huang X; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Jing H; Department of Pharmacy, China-Japan Friendship Hospital, Beijing, China.
  • Ke X; Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
  • Li G; Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Miao L; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center/National Clinical Research Center for Cancer, Beijing, China.
  • Niu X; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
  • Qiu F; Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China.
  • Shen J; Institute of Clinical Pharmacology, Qilu Hospital of Shandong University, Jinan, China.
  • Tang J; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Wang T; Department of Pharmacy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang X; Peking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Wang Z; Department of Hematology, Peking University Third Hospital, Beijing, China.
  • Wu J; Department of Hematology, Peking University Third Hospital, Beijing, China.
  • Zhan S; Department of Pharmacy, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center/National Clinical Research Center for Cancer, Beijing, China.
  • Zhang B; Department of Clinical Pharmacology, First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang L; Department of Orthopedic Oncology, Beijing Jishuitan Hospital and Fourth Medical College of Peking University, Beijing, China.
  • Zhang Y; Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Zhang W; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Zhao L; Department of Hematology/Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Key Lab of Pediatric Hematology & Oncology of China Ministry of Health, Shanghai, China.
  • Zhao L; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Zhen J; Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, Beijing, China.
  • Zheng H; Department of Pharmacy, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
  • Zhu Z; Pharmacy Department, The 306th Hospital of PLA, Beijing, China.
  • Jiang D; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
  • Huang Z; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
  • Tan Z; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Lin Q; Department of Pharmacy/Evidence-Based Pharmacy Centre, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Zhao R; Department of Pharmacy, Peking University Cancer Hospital and Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China.
Br J Clin Pharmacol ; 88(5): 2456-2472, 2022 05.
Article em En | MEDLINE | ID: mdl-34729817
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metotrexato / Monitoramento de Medicamentos Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metotrexato / Monitoramento de Medicamentos Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China